Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? (Q34564943)

3 August 2017

1 reference

title

Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? (English)

1 reference

adaptive radiation therapy

3 August 2017

main subject

0 references

1 reference

Ralph W Moss

1

1 reference

3 August 2017

publication date

1 March 2006

1 reference

Integrative Cancer Therapies

3 August 2017

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

63-82

1 reference

Use of antioxidants during chemotherapy and radiotherapy should be avoided.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

The use of antioxidant therapies during chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Beta-carotene and other carotenoids as antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Antioxidant and prooxidant properties of carotenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Implications for tumor control during protection of normal tissues with antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Vitamin C pharmacokinetics: implications for oral and intravenous use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Orthomolecular oncology review: ascorbic acid and cancer 25 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Comments on "Mega-dose vitamins and minerals in the treatment of nonmetastatic breast cancer: an historical cohort study".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

A clinicopathologic analysis of adriamycin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

New careers for antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

The therapeutic application of melatonin in supportive care and palliative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Thrombopoietic properties of 5-methoxytryptamine plus melatonin versus melatonin alone in the treatment of cancer-related thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Cancer and complementary and alternative medicine in Italy: personal observations and historical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Alterations of nutritional status.Impact of chemotherapy and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Intraocular inflammation in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Isoflavonoids from Astragalus mongholicus protect PC12 cells from toxicity induced by L-glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

8-oxo-dG elevated in children during leukemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Causes of peptic ulcer. A selective epidemiologic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

Why most published research findings are false

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735405285882

21 January 2018

Identifiers

DOI

10.1177/1534735405285882

1 reference

3 August 2017

1 reference